These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
3. Specificity of human glucosylceramide beta-glucosidase towards synthetic glucosylsphingolipids inserted into liposomes. Kinetic studies in a detergent-free assay system. Sarmientos F, Schwarzmann G, Sandhoff K. Eur J Biochem; 1986 Nov 03; 160(3):527-35. PubMed ID: 3780720 [Abstract] [Full Text] [Related]
4. Comparison of synthetic and natural glucosylceramides as substrate for glucosylceramidase assay. Vaccaro AM, Kobayashi T, Suzuki K. Clin Chim Acta; 1982 Jan 05; 118(1):1-7. PubMed ID: 7053901 [Abstract] [Full Text] [Related]
6. Glucosylceramide and the level of the glucosidase-stimulating proteins. Datta SC, Radin NS. Lipids; 1986 Nov 05; 21(11):702-9. PubMed ID: 3099116 [Abstract] [Full Text] [Related]
8. The fate of glucosylceramide (glucocerebroside) in genetically impaired (lysosomal beta-glucosidase deficient) Gaucher disease diploid human fibroblasts. Saito M, Rosenberg A. J Biol Chem; 1985 Feb 25; 260(4):2295-300. PubMed ID: 3919000 [Abstract] [Full Text] [Related]
9. Mechanism of activation of glucocerebrosidase by co-beta-glucosidase (glucosidase activator protein). Berent SL, Radin NS. Biochim Biophys Acta; 1981 Jun 23; 664(3):572-82. PubMed ID: 6268176 [Abstract] [Full Text] [Related]
11. Correlation between the activity of glucosylceramidase and its binding to glucosylceramide-containing liposomes. Role of acidic phospholipids and fatty acids. Vaccaro AM, Tatti M, Salvioli R, Ciaffoni F, Gallozzi E. Biochim Biophys Acta; 1990 Jan 29; 1033(1):73-9. PubMed ID: 2302413 [Abstract] [Full Text] [Related]
12. Activation of membrane-bound glucosylceramide: beta-glucosidase in fibroblasts cultured from normal and glucosylceramidotic human skin. Mueller OT, Rosenberg A. J Biol Chem; 1979 May 10; 254(9):3521-5. PubMed ID: 429368 [No Abstract] [Full Text] [Related]
13. Presence of activator proteins for the enzymatic degradation of glucosylceramide in several human tissues. Vaccaro AM, Ciaffoni F, Mandara I, Suzuki K. Clin Chim Acta; 1988 Mar 15; 172(2-3):323-34. PubMed ID: 3370844 [Abstract] [Full Text] [Related]
17. Gaucher disease. III. Substrate specificity of glucocerebrosidase and the use of nonlabeled natural substrates for the investigation of patients. Choy FY, Davidson RG. Am J Hum Genet; 1980 Sep 15; 32(5):670-80. PubMed ID: 6775530 [Abstract] [Full Text] [Related]
18. Glycosphingolipid studies of visceral tissues and brain from type 1 Gaucher disease variants. Nilsson O, Grabowski GA, Ludman MD, Desnick RJ, Svennerholm L. Clin Genet; 1985 May 15; 27(5):443-50. PubMed ID: 3924448 [Abstract] [Full Text] [Related]
19. Studies of the pathogenesis of Gaucher's disease: tissue distribution and biliary excretion of [14C]L-glucosylceramide in rats. Tokoro T, Gal AE, Gallo LL, Brady RO. J Lipid Res; 1987 Aug 15; 28(8):968-72. PubMed ID: 3668390 [Abstract] [Full Text] [Related]
20. Salvage of glucosylceramide by recycling after internalization along the pathway of receptor-mediated endocytosis. Kok JW, Eskelinen S, Hoekstra K, Hoekstra D. Proc Natl Acad Sci U S A; 1989 Dec 15; 86(24):9896-900. PubMed ID: 2690077 [Abstract] [Full Text] [Related] Page: [Next] [New Search]